Related NCI Initiatives
Cancer-specific proteins, present in low concentrations in the blood, are detected by capturing them on magnetic sensors and tagging them with magnetic nanoparticles by the MagArray device devloped by Stanford University Professor Shan Wang.
Credit: National Cancer Institute & Stanford University
The Alliance for Nanotechnology in Cancer program is dedicated to the innovative use of nanotechnologies in new cancer diagnostics and therapeutics. The program is part of a much larger funding system of the Division of Cancer Treatment and Diagnosis and NCI with several complimentary funding opportunities. Please visit other programs and offices websites within the NCI's Division of Cancer Treatment and Diagnosis to review these funding opportunities.
- Biometric Research Program (BRP)
- Cancer Diagnosis Program (CDP)
- Cancer Imaging Program (CIP)
- Cancer Therapy Evaluation Program (CTEP)
- Developmental Therapeutics Program (DTP)
- Radiation Research Program (RRP)
- Translational Research Program (TRP)
- Office of Cancer Complementary and Alternative Medicine (OCCAM)
- Office of Cancer Clinical Proteomics Research